GlucoTrack Inc (GCTK) FinancialsGCTKFinancialGlucoTrack Inc

Evaluating the bottom line, GlucoTrack Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -527.20%, provide a clear picture of how effectively GCTK converts its operational activities into shareholder value.

In the context of the broader market, GCTK competes directly with industry leaders such as BIAF and NUWE. With a market capitalization of $2.98M, it holds a significant position in the sector. When comparing efficiency, GCTK's gross margin of N/A stands against BIAF's 23.91% and NUWE's 76.08%. Such benchmarking helps identify whether GlucoTrack Inc is trading at a premium or discount relative to its financial performance.

GlucoTrack has reported continuous net losses, with the latest net income showing a loss of $4,334,000 in Q1 2026. The company's current ratio is low at 0.85, indicating potential liquidity issues.